Wherefore interferon?

被引:68
作者
Gresser, I
机构
[1] Laboratory of Viral Oncology, Ctr. Natl. de la Rech. Scientifique, Villejuif
[2] Laboratory of Viral Oncology, Ctr. Natl. de la Rech. Scientifique, IFC1, 94801 Villejuif Cedex
关键词
antitumor activity; induction of disease; effect on immune system; clinical use;
D O I
10.1002/jlb.61.5.567
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interferon (IFN) was discovered by virologists interested in the phenomenon of viral interference and for many years was considered to be exclusively an antiviral substance, In time, it was accepted that the antiviral action was only one manifestation of the multiple effects of IFN on cells, IFN was shown to inhibit the development of tumors, to modulate immune function, and even to induce disease, Some aspects of these phenomena will be discussed, Despite this plethora of biological effects of type I IFN, the potency of its antiviral action, combined with its varied effects on both the cell-mediated and humoral immune response, render it a most effective and remarkable antiviral substance, Arguments will be presented to support the hypothesis that the major role of IFN is, after all, in antiviral defense, Finally, the use of type I IFN in the treatment of patients with viral and neoplastic diseases and even diseases of varied and unknown etiology is discussed.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 109 条
[1]   ISOLATION OF INTERFERON-RESISTANT VARIANTS OF FRIEND-ERYTHROLEUKEMIA CELLS - EFFECTS OF INTERFERON AND OUABAIN [J].
AFFABRIS, E ;
JEMMA, C ;
ROSSI, GB .
VIROLOGY, 1982, 120 (02) :441-452
[2]  
Andrewes CH, 1942, BRIT J EXP PATHOL, V23, P214
[3]   INJECTION OF MICE WITH ANTIBODY TO INTERFERON RENDERS PERITONEAL-MACROPHAGES PERMISSIVE FOR VESICULAR STOMATITIS-VIRUS AND ENCEPHALOMYOCARDITIS VIRUS [J].
BELARDELLI, F ;
VIGNAUX, F ;
PROIETTI, E ;
GRESSER, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (02) :602-606
[4]   The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372
[5]   ANTI-TUMOR EFFECTS OF INTERFERON IN MICE INJECTED WITH INTERFERON-SENSITIVE AND INTERFERON-RESISTANT FRIEND-LEUKEMIA CELLS .1. [J].
BELARDELLI, F ;
GRESSER, I ;
MAURY, C ;
MAUNOURY, MT .
INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (06) :813-820
[6]   ANTI-TUMOR EFFECTS OF INTERFERON IN MICE INJECTED WITH INTERFERON-SENSITIVE AND INTERFERON-RESISTANT FRIEND-LEUKEMIA CELLS .3. INHIBITION OF GROWTH AND NECROSIS OF TUMORS IMPLANTED SUBCUTANEOUSLY [J].
BELARDELLI, F ;
GRESSER, I ;
MAURY, C ;
DUVILLARD, P ;
PRADE, M ;
MAUNOURY, MT .
INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (05) :649-653
[7]   THE PHYSIOLOGICAL INTERFERON RESPONSE [J].
BOCCI, V .
IMMUNOLOGY TODAY, 1985, 6 (01) :7-9
[8]  
BRODEUR BR, 1974, J IMMUNOL, V113, P1319
[9]   INHIBITION OF CELL MOTILITY BY INTERFERON [J].
BROUTYBOYE, D ;
ZETTER, BR .
SCIENCE, 1980, 208 (4443) :516-518
[10]  
CANTELL K, 1979, INTERFERON, V1, P1